» Articles » PMID: 34822430

Pattern of Adiponectin, Osteocalcin, Irisin, FGF-21, and MCP-1 According to the Body Size Phenotype: Could They Be Markers of Metabolic Health in Mexican-Mestizo Middle-Aged Women?

Overview
Journal Metabolites
Publisher MDPI
Date 2021 Nov 25
PMID 34822430
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Variations in levels of some adipokines, myokines, osteokines, hepatokines and inflammatory cytokines contribute to abnormal glucose and lipid metabolism. The aim of this study was to determine the pattern of adiponectin, osteocalcin (OCN), irisin, FGF-21, and MCP-1 according to the body size phenotype of middle-aged women, and their associations with BMI, visceral adipose tissue (VAT), and HOMA-IR. A cross-sectional study in 265 women aged from 40 to 65 years was performed. The biochemical characteristics were evaluated in metabolically healthy normal weight, metabolically unhealthy normal weight, metabolically healthy obese, and metabolically unhealthy obese women. There was an association of OCN with BMI (r = -0.107; = 0.047); adiponectin with BMI (r = -0.217; = 0.001), insulin (r = -0.415; = 0.0001), HOMA-IR (r = -0.429; = 0.0001), and VAT (r = -0.134; = 0.025); irisin with BMI (r = 0.604; = 0.001), insulin (r = 0.446; = 0.0001), HOMA-IR (r = 0.452; = 0.0001), and VAT (r = 0.645; = 0.0001); FGF-21 with insulin (r = -0.337; = 0.030) and HOMA-IR (r = -0.341; = 0.03); and MCP-1 with BMI (r = 0.481; = 0.0001), VAT (r = 0.497; = 0.001), insulin (r = 0.298; = 0.001), and HOMA-IR (r = 0.255; = 0.004). A multivariate analysis showed that an elevation of OCN (OR 1.4 (CI 1.06-1.81)) and a reduction of adiponectin (OR 0.9 (0.84-0.96)) were associated factors for a metabolic unhealthy phenotype in normal weight participants. Likewise, higher irisin (OR 1.007 (1.003-1.011)) and MCP-1 (1.044 (1.008-1.083)) were risk factors for a metabolic unhealthy phenotype in woman with obesity. OCN, adiponectin, irisin, FGF-21, and MCP-1 are associated with some metabolic parameters such as BMI, HOMA-IR, and VAT, and could be possible biomarkers of an unhealthy metabolic phenotype in middle-aged women.

Citing Articles

A comparison of brown fat tissue related hormone levels in metabolically healthy and unhealthy individuals with obesity.

Mutlu H, Koc Ada S, Uzunlulu M, Mutlu H, Sargin M, Oguz A Endocrine. 2024; 86(3):1025-1034.

PMID: 39008201 PMC: 11554687. DOI: 10.1007/s12020-024-03960-8.

References
1.
Landecho M, Tuero C, Valenti V, Bilbao I, De La Higuera M, Fruhbeck G . Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. Nutrients. 2019; 11(11). PMC: 6893824. DOI: 10.3390/nu11112664. View

2.
Wang B, Zhuang R, Luo X, Yin L, Pang C, Feng T . Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis. Horm Metab Res. 2015; 47(11):839-45. DOI: 10.1055/s-0035-1559767. View

3.
Leung W, Yu A, Lai C, Siu P . Association of Markers of Proinflammatory Phenotype and Beige Adipogenesis with Metabolic Syndrome in Chinese Centrally Obese Adults. J Diabetes Res. 2018; 2018:8956509. PMC: 5835251. DOI: 10.1155/2018/8956509. View

4.
Ferreira F, Juvanhol L, Silva D, Longo G . Visceral adiposity index is a better predictor of unhealthy metabolic phenotype than traditional adiposity measures: results from a population-based study. Public Health Nutr. 2018; 22(9):1545-1554. PMC: 10261056. DOI: 10.1017/S136898001800335X. View

5.
Karelis A, Brochu M, Rabasa-Lhoret R . Can we identify metabolically healthy but obese individuals (MHO)?. Diabetes Metab. 2005; 30(6):569-72. DOI: 10.1016/s1262-3636(07)70156-8. View